SEC Form 4 · accession 0001179110-15-005947

YIELD10 BIOSCIENCE, INC. · YTEN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP Marketing and Corp Comm

Period of report

Apr 1, 2015

Accepted (ET)

Apr 3, 2015 · 3:32 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001121702

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Apr 1, 2015	A	74,405	$0.00	A	84,405	D
Common Stock^F1,F3	Apr 1, 2015	A	470,000	$0.00	A	554,405	D
Common Stock^F4	holding	—	—		—	25,043	I	By 401(k) Plan

No Table II lines on this filing.

F1The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Issuer's 2014 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2These RSUs were issued pursuant to the reporting person's election to convert a portion of her 2014 performance bonus from cash to equity. The RSUs will vest in their entirety on April 1, 2016. All RSUs that have not vested will automatically terminate if the reporting person's employment is terminated by the Company for cause or the reporting person voluntarily terminates her employment with the Company, subject to certain acceleration provisions set forth in the reporting person's employment agreement.
F3These RSUs were granted as part of the Issuer's long term incentive program for executive officers. The RSUs will vest in four (4) equal annual installments beginning on April 1, 2016. All RSUs that have not vested will automatically terminate upon the reporting person's termination of employment with the Issuer and its subsidiaries, subject to certain acceleration provisions set forth in the reporting person's employment agreement.
F4Shares acquired as Company matching contributions under the Metabolix, Inc. 401(k) Plan.